Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Rutgeerts, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 286 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nevens, F; Rutgeerts, P
      Variceal band ligation in the management of bleeding oesophageal varices: an overview

      DIGESTIVE AND LIVER DISEASE
    2. Simoens, M; Rutgeerts, P
      Non-variceal upper gastrointestinal bleeding

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    3. Rutgeerts, P; Geboes, K
      Understanding inflammatory bowel disease - The clinician's perspective

      EUROPEAN JOURNAL OF SURGERY
    4. Baert, F; Rutgeerts, P
      6-Thioguanine: A naked bullet? (or how pharmacogenomics can make old drugsbrand new)

      INFLAMMATORY BOWEL DISEASES
    5. Vermeire, S; Peeters, M; Vlietinck, R; Joossens, S; Den Hond, E; Bulteel, V; Bossuyt, X; Geypens, B; Rutgeerts, P
      Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families

      INFLAMMATORY BOWEL DISEASES
    6. Rutgeerts, P
      The use of budesonide in the treatment of active Crohn's disease is good clinical practice

      INFLAMMATORY BOWEL DISEASES
    7. Bennink, R; Peeters, M; D'Haens, G; Rutgeerts, P; Mortelmans, L
      Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extentand severity of an acute exacerbation of ulcerative colitis

      CLINICAL NUCLEAR MEDICINE
    8. Rector, A; Vermeire, S; Thoelen, I; Keyaerts, E; Struyf, F; Vlietinck, R; Rutgeerts, P; Van Ranst, M
      Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease

      HUMAN GENETICS
    9. Carty, E; Rampton, DS; Schneider, H; Rutgeerts, P; Wright, JP
      Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    10. Cornillie, F; Shealy, D; D'Haens, G; Geboes, K; Van Assche, G; Ceuppens, J; Wagner, C; Schaible, T; Plevy, SE; Targan, SR; Rutgeerts, P
      Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    11. Colpaert, S; Liu, Z; De Greef, B; Rutgeerts, P; Ceuppens, JL; Geboes, K
      Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    12. Schreiber, S; Campieri, M; Colombel, JF; van Deventer, SJH; Feagan, B; Fedorak, R; Forbes, A; Gassull, M; Gendre, JP; van Hogezand, RA; Lofberg, R; Modigliani, R; Pallone, F; Petritsch, W; Prantera, C; Rampton, D; Seibold, F; Vatn, M; Zeitz, M; Rutgeerts, P
      Use of anti-tumour necrosis factor agents in inflammatory bowel disease - European guidelines for 2001-2003

      INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
    13. Miguel, JC; Cuesta, MA; Rutgeerts, P; Korelitz, BI; Rajapakse, RO; Garcia-Aguilar, J
      Treatment of perianal and fistulizing Crohn's disease

      DRUGS OF TODAY
    14. Rutgeerts, P
      Anti-TNF-alpha treatment for perianal fistulizing Crohn's disease

      DRUGS OF TODAY
    15. Liu, ZJ; Geboes, K; Hellings, P; Maerten, P; Heremans, H; Vandenberghe, P; Boon, L; van Kooten, P; Rutgeerts, P; Ceuppens, JL
      B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis

      JOURNAL OF IMMUNOLOGY
    16. Colombel, JF; Rutgeerts, P; Malchow, H; Jacyna, M; Nielsen, OH; Rask-Madsen, J; Van Deventer, S; Ferguson, A; Desreumaux, P; Forbes, A; Geboes, K; Melani, L; Cohard, M
      Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease

      GUT
    17. Rutgeerts, P
      Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease

      GUT
    18. Cortot, A; Colombel, JF; Rutgeerts, P; Lauritsen, K; Malchow, H; Hamling, J; Winter, T; Van Gossum, A; Persson, T; Pettersson, E
      Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease

      GUT
    19. D'Haens, G; Lemmens, L; Geboes, K; Vandeputte, L; Van Acker, F; Mortelmans, L; Peeters, M; Vermeire, S; Penninckx, F; Nevens, F; Hiele, M; Rutgeerts, P
      Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

      GASTROENTEROLOGY
    20. Vermeire, S; Joossens, S; Peeters, M; Monsuur, F; Marien, G; Bossuyt, X; Groenen, P; Vlietinck, R; Rutgeerts, P
      Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease

      GASTROENTEROLOGY
    21. Vermeire, S; Satsangi, J; Peeters, M; Parkes, M; Jewell, DP; Vlietinck, R; Rutgeerts, P
      Evidence for inflammatory dowel disease of a susceptibility locus on the xchromosome

      GASTROENTEROLOGY
    22. Liu, ZJ; Geboes, K; Heremans, H; Overbergh, L; Mathieu, C; Rutgeerts, P; Ceuppens, JL
      Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis

      EUROPEAN JOURNAL OF IMMUNOLOGY
    23. D'Haens, G; Swijsen, C; Noman, M; Lemmens, L; Ceuppens, J; Agbahiwe, H; Geboes, K; Rutgeerts, P
      Etanercept in the treatment of active refractory Crohn's disease: A single-center pilot trial

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    24. Peeters, M; Joossens, S; Vermeire, S; Vlietinck, R; Bossuyt, X; Rutgeerts, P
      Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    25. Rutgeerts, P
      Biological therapies for Inflammatory bowel diseases: Are we finally goingto modify the disease course?

      ACTA GASTRO-ENTEROLOGICA BELGICA
    26. Hiele, M; Rutgeerts, P
      Combination therapies for the endoscopic treatment of gastrointestinal bleeding

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    27. Van Assche, G; Rutgeerts, P
      Anti-TNF agents in Crohn's disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    28. Vermeire, S; Peeters, M; Vlietinck, R; Parkes, M; Satsangi, J; Jewell, D; Rutgeerts, P
      Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity

      INFLAMMATORY BOWEL DISEASES
    29. Rutgeerts, P
      Infliximab is the drug we have been waiting for in Crohn's disease

      INFLAMMATORY BOWEL DISEASES
    30. Craninx, M; D'Haens, G; Cokelaere, K; Baert, F; Penninckx, F; D'Hoore, A; Ectors, N; Rutgeerts, P; Geboes, K
      Crohn's disease and intestinal endometriosis: an intriguing co-existence

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    31. Suenaert, P; Bulteel, V; Den Hond, E; Hiele, M; Peeters, M; Monsuur, F; Ghoos, Y; Rutgeerts, P
      The effects of smoking and indomethacin on small intestinal permeability

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    32. Vermeire, S; Peeters, M; Rutgeerts, P
      Diagnostic approach to IBD

      HEPATO-GASTROENTEROLOGY
    33. Rutgeerts, P; Vermeire, S
      Serological diagnosis of inflammatory bowel disease

      LANCET
    34. Cortot, A; Colombel, JF; Rutgeerts, P; Lauritsen, K; Malchow, H; Hamling, J; Winter, T; van Gossum, A; Persson, T; Pettersson, E
      Switch from systemic steroids to budesonide in steroid-dependent patients with inactive Crohn's disease

      DRUGS OF TODAY
    35. Rutgeerts, P; Baert, F
      Novel therapies for Crohn's disease

      DRUGS OF TODAY
    36. Campieri, M; Cohen, Z; Griffiths, A; Ejderhamm, J; Lofberg, R; Rutgeerts, P; Sachar, D; Tremaine, W; Vatn, M
      Session II and III panel discussion

      DRUGS OF TODAY
    37. Pena, AS; Manoliu, RA; Bloemena, E; Cohen, A; Lobo, A; Rutgeerts, P; Sachar, D
      Case presentation: Mild to moderate Crohn's disease of the small and largebowel

      DRUGS OF TODAY
    38. Rutgeerts, P; Cohen, Z; Sachar, D; Tremaine, W
      Case presentation: Refractory Crohn's disease

      DRUGS OF TODAY
    39. Vatn, M; Cohen, Z; Cortot, A; Lobo, A; Rutgeerts, P; Sachar, D; Tremaine, W
      Case presentation: Postoperative prophylaxis

      DRUGS OF TODAY
    40. Lofberg, R; Cohen, Z; Cortot, A; Ejderhamm, J; Gomollon, F; Graffner, H; Griffiths, A; Lobo, A; Rutgeerts, P; Sachar, D; Stange, E; Tremaine, W; Vatn, M
      Case presentation: Extensive colorectal Crohn's disease

      DRUGS OF TODAY
    41. Stange, E; Cohen, Z; Gomollon, F; Lobo, A; Lofberg, R; Pena, AS; Rutgeerts, P; Sachar, D; Tremaine, W
      Case presentation: Steroid refractory colitis

      DRUGS OF TODAY
    42. Cortot, A; Cohen, Z; Ejderhamm, J; Rutgeerts, P; Stange, E; Tremaine, W
      Case presentation: Corticodependent Crohn's disease

      DRUGS OF TODAY
    43. Tremaine, W; Lofberg, R; Rutgeerts, P; Sachar, D; Stange, E
      Case presentation: Crohn's disease with perianal involvement

      DRUGS OF TODAY
    44. Cohen, Z; Lofberg, R; Rutgeerts, P
      Case presentation: Rectal remnant complications

      DRUGS OF TODAY
    45. Liu, ZJ; Geboes, K; Colpaert, S; D'Haens, GR; Rutgeerts, P; Ceuppens, JL
      IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production

      JOURNAL OF IMMUNOLOGY
    46. Liu, ZJ; Geboes, K; Colpaert, S; Overbergh, L; Mathieu, C; Heremans, H; de Boer, M; Boon, L; D'Haens, G; Rutgeerts, P; Ceuppens, JL
      Prevention of experimental colitis in SCID mice reconstituted with CD45RB(high) CD4(+) T cells by blocking the CD40-CD154 interactions

      JOURNAL OF IMMUNOLOGY
    47. Evenepoel, P; Hiele, M; Geypens, B; Geboes, KP; Rutgeerts, P; Ghoos, Y
      C-13-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine

      GUT
    48. Gevers, AM; Macken, E; Hiele, M; Rutgeerts, P
      Endoscopic laser therapy for palliation of patients with distal colorectalcarcinoma: analysis of factors influencing long-term outcome

      GASTROINTESTINAL ENDOSCOPY
    49. Waye, JD; Bornman, PC; Kawai, K; Rutgeerts, P; Speer, T
      Teaching basic endoscopy

      GASTROINTESTINAL ENDOSCOPY
    50. Schreiber, S; Fedorak, RN; Nielsen, OH; Wild, G; Williams, CN; Nikolaus, S; Jacyna, M; Lashner, BA; Gangl, A; Rutgeerts, P; Isaacs, K; Van Deventer, SJH; Koningsberger, JC; Cohard, M; LeBeaut, A; Hanauer, SB
      Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease

      GASTROENTEROLOGY
    51. Fedorak, RN; Gangl, A; Elson, CO; Rutgeerts, P; Schreiber, S; Wild, G; Hanauer, SB; Kilian, A; Cohard, M; LeBeaut, A; Feagan, B
      Recombinant human interleukin 10 in the treatment of patients with mild tomoderately active Crohn's disease

      GASTROENTEROLOGY
    52. Louis, E; Peeters, M; Franchimont, D; Seidel, L; Fontaine, F; Demolin, G; Croes, F; Dupont, P; Davin, L; Omri, S; Rutgeerts, P; Belaiche, J
      Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    53. Ghoos, Y; Geypens, B; Rutgeerts, P
      (CO2)-C-13 Breath tests and stable isotopes for investigating gastrointestinal functions

      ACTA GASTRO-ENTEROLOGICA BELGICA
    54. D'Haens, G; Rutgeerts, P
      Postoperative recurrence of Crohn's disease: Pathophysiology and prevention

      INFLAMMATORY BOWEL DISEASES
    55. Vandeputte, L; D'Haens, G; Baert, F; Rutgeerts, P
      Methotrexate in refractory Crohn's disease

      INFLAMMATORY BOWEL DISEASES
    56. Geypens, B; Claus, D; Gorris, N; Evenepoel, P; Luypaerts, A; Rutgeerts, P; Ghoos, Y
      Determination of deuterated phenylalanine and tyrosine in egg protein by GCQ

      HRC-JOURNAL OF HIGH RESOLUTION CHROMATOGRAPHY
    57. Geboes, K; Rutgeerts, P
      Dysplasia in inflammatory bowel diseases: Definition and clinical impact

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    58. Bennink, R; Peeters, M; Van den Maegdenbergh, V; Geypens, B; Rutgeerts, P; De Roo, M; Mortelmans, L
      Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    59. Den Hond, E; Peeters, M; Hiele, M; Bulteel, V; Ghoos, Y; Rutgeerts, P
      Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans.

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    60. Evenepoel, P; Claus, D; Geypens, B; Hiele, M; Geboes, K; Rutgeerts, P; Ghoos, Y
      Amount and fate of egg protein escaping assimilation in the small intestine of humans

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    61. Simoens, M; Gevers, AM; Rutgeerts, P
      Endoscopic therapy for upper gastrointestinal hemorrhage: A state of the art

      HEPATO-GASTROENTEROLOGY
    62. Geypens, B; Bennink, R; Peeters, M; Evenepoel, P; Mortelmans, L; Maes, B; Ghoos, Y; Rutgeerts, P
      Validation of the lactose-[C-13]ureide breath test for determination of orocecal transit time by scintigraphy

      JOURNAL OF NUCLEAR MEDICINE
    63. Den Hond, E; Hiele, M; Peeters, M; Ghoos, Y; Rutgeerts, P
      Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease

      JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
    64. Present, DH; Rutgeerts, P; Targan, S; Hanauer, SB; Mayer, L; van Hogezand, RA; Podolsky, DK; Sands, BE; Braakman, T; DeWoody, KL; Schaible, TF; van Deventer, SJH
      Infliximab for the treatment of fistulas in patients with Crohn's disease

      NEW ENGLAND JOURNAL OF MEDICINE
    65. Pena, AS; Meuwissen, SGM; Falke, TJM; Cuesta, MA; Hanauer, SB; Rutgeerts, P; Tremaine, BW; Gassull, MA; Cortot, A; Cohen, Z
      Inflammatory bowel disease. A case presentation from Amsterdam with a panel discussion in Barcelona

      DRUGS OF TODAY
    66. Liu, ZJ; Colpaert, S; D'Haens, GR; Kasran, A; de Boer, M; Rutgeerts, P; Geboes, K; Ceuppens, JL
      Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production

      JOURNAL OF IMMUNOLOGY
    67. D'Haens, G; Geboes, K; Rutgeerts, P
      Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

      GASTROINTESTINAL ENDOSCOPY
    68. Rutgeerts, P; Wang, TH; Llorens, PS
      Gastrointestinal endoscopy and the patient with a risk of bleeding disorder

      GASTROINTESTINAL ENDOSCOPY
    69. Rutgeerts, P; D'Haens, G; Targan, S; Vasiliauskas, E; Hanauer, SB; Present, DH; Mayer, L; Van Hogezand, RA; Braakman, T; DeWoody, KL; Schaible, TF; Van Deventer, SJH
      Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

      GASTROENTEROLOGY
    70. D'Haens, G; Van Deventer, S; Van Hogezand, R; Chalmers, D; Kothe, C; Baert, F; Braakman, T; Schaible, T; Geboes, K; Rutgeerts, P
      Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

      GASTROENTEROLOGY
    71. Hellers, G; Cortot, A; Jewell, D; Leijonmarck, CE; Lofberg, R; Malchow, H; Nilsson, LG; Pallone, F; Pena, S; Persson, T; Prantera, C; Rutgeerts, P
      Oral budesonide for prevention of postsurgical recurrence in Crohn's disease

      GASTROENTEROLOGY
    72. Rutgeerts, P; Baert, F
      New strategies in the management of inflammatory bowel disease.

      ACTA CLINICA BELGICA
    73. Rutgeerts, P; Baert, F
      Immunosuppressive drugs in the treatment of Crohn's disease

      EUROPEAN JOURNAL OF SURGERY
    74. DHAENS G; SUENAERT P; WESTHOVENS R; RUTGEERTS P
      SEVERE KNEE PAIN AS THE SINGLE SYMPTOM OF CMV INFECTION IN ACUTE ULCERATIVE-COLITIS TREATED WITH CYCLOSPORINE

      Inflammatory bowel diseases
    75. RUTGEERTS P
      THE USE OF ORAL TOPICALLY ACTING GLUCOCORTICOSTEROIDS IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE

      Mediators of inflammation
    76. PERRI F; CLEMENTE R; FESTA V; QUITADAMO M; CONOSCITORE P; NIRO G; GHOOS Y; RUTGEERTS P; ANDRIULLI A
      RELATIONSHIP BETWEEN THE RESULTS OF PRETREATMENT UREA BREATH TEST ANDEFFICACY OF ERADICATION OF HELICOBACTER-PYLORI INFECTION

      The Italian Journal of Gastroenterology
    77. RUTGEERTS P
      AN INDEPENDENT VERDICT - DRUG PROPHYLAXIS OF RECURRENCE OF CROHNS-DISEASE AFTER RESECTION - THE WAY TO GO

      The Italian Journal of Gastroenterology
    78. BENNINK R; PEETERS M; VANDENMAEGDENBERGH V; GEYPENS B; RUTGEERTS P; DEROO M; MORTELMANS L
      COMPARISON OF TOTAL AND COMPARTMENTAL GASTRIC-EMPTYING AND ANTRAL MOTILITY BETWEEN HEALTHY-MEN AND WOMEN

      European journal of nuclear medicine
    79. PERRI F; PASTORE M; CLEMENTE R; FESTA V; QUITADAMO M; NIRO G; CONOSCITORE P; RUTGEERTS P; ANDRIULLI A
      HELICOBACTER-PYLORI INFECTION MAY UNDERGO SPONTANEOUS ERADICATION IN CHILDREN - A 2-YEAR FOLLOW-UP-STUDY

      Journal of pediatric gastroenterology and nutrition
    80. DHAENS G; VERSTRAETE A; CHEYNS K; AERDEN I; BOUILLON R; RUTGEERTS P
      BONE TURNOVER DURING SHORT-TERM THERAPY WITH METHYLPREDNISOLONE OR BUDESONIDE IN CROHNS-DISEASE

      Alimentary pharmacology & therapeutics
    81. EVENEPOEL P; CLAUS D; GEYPENS B; MAES B; HIELE M; RUTGEERTS P; GHOOS Y
      EVIDENCE FOR IMPAIRED ASSIMILATION AND INCREASED COLONIC FERMENTATIONOF PROTEIN, RELATED TO GASTRIC-ACID SUPPRESSION THERAPY

      Alimentary pharmacology & therapeutics
    82. DHAENS G; RUTGEERTS P
      MEDICAL THERAPY FOR CROHNS-DISEASE

      Current opinion in gastroenterology
    83. VERMIERE S; RUTGEERTS P
      MEDICINAL PROPHYLAXIS OF RECURRENCE OF CR OHNS-DISEASE IN THE NEOTERMINAL ILEUM AFTER ILEAL RESECTION

      Zentralblatt fur Chirurgie
    84. PERRI F; CLEMENTE R; PASTORE M; QUITADAMO M; FESTA V; BISCEGLIA M; LIBERGOLI M; LAURIOLA G; LEANDRO G; GHOOS Y; RUTGEERTS P; ANDRIULLI A
      THE C-13-UREA BREATH TEST AS A PREDICTOR OF INTRAGASTRIC BACTERIAL LOAD AND SEVERITY OF HELICOBACTER-PYLORI GASTRITIS

      Scandinavian journal of clinical & laboratory investigation
    85. EVENEPOEL P; GEYPENS B; LUYPAERTS A; HIELE M; GHOOS Y; RUTGEERTS P
      DIGESTIBILITY OF COOKED AND RAW EGG PROTEIN IN HUMANS AS ASSESSED BY STABLE-ISOTOPE TECHNIQUES

      The Journal of nutrition
    86. GHOOS Y; BEAUFRERE B; BOIRIE Y; FAUQUANT J; EVENEPOEL P; GEYPENS B; HIELE M; RUTGEERTS P
      THE PRODUCTION OF MILK AND EGG PROTEINS, ENRICHED WITH STABLE ISOTOPES, FOR THE IN-VIVO STUDY OF PROTEIN ASSIMILATION AND METABOLISM DURINGFEEDING - AN EUROPEAN COLLABORATIVE STUDY

      Gut
    87. EVENEPOEL P; HIELE M; GEYPENS B; RUTGEERTS P; GHOOS Y
      PROTEIN ASSIMILATION IN NORMAL SUBJECTS AND PATIENTS WITH PANCREATIC DISEASE, STUDIED WITH A C-13 EGG-WHITE BREATH TEST

      Gut
    88. MAES B; GEYPENS B; LUYPAERTS A; GHOOS Y; RUTGEERTS P
      MEAL-TO-MEAL VARIABILITY OF GASTRIC-EMPTYING OF SOLIDS IN MAN

      Gut
    89. GRANDBASTIEN B; PEETERS M; FRANCHIMONT D; GOWERROUSSEAU C; SPECKEL D; RUTGEERTS P; BELAICHE J; CORTOT A; VLIETINCK R; COLOMBEL JF
      ANTICIPATION IN FAMILIAL CROHNS-DISEASE

      Gut
    90. GEVERS AM; MACKEN E; HIELE M; RUTGEERTS P
      A COMPARISON OF LASER THERAPY, PLASTIC STENTS, AND EXPANDABLE METAL STENTS FOR PALLIATION OF MALIGNANT DYSPHAGIA IN PATIENTS WITHOUT A FISTULA

      Gastrointestinal endoscopy
    91. TACK J; GEVERS AM; RUTGEERTS P
      SELF-EXPANDABLE METALLIC STENTS IN THE PALLIATION OF RECTOSIGMOIDAL CARCINOMA - A FOLLOW-UP-STUDY

      Gastrointestinal endoscopy
    92. DEGOEDE E; GEVERS AM; SIMOENS M; HIELE M; RUTGEERTS P
      INTERIM RESULTS OF A RANDOMIZED TRIAL COMPARING INJECTION THERAPY WITH EPINEPHRINE-POLIDOCANOL 1-PERCENT VERSUS HEMOCLIP VERSUS INJECTION COMBINED WITH HEMOCLIP FOR BLEEDING ULCERS

      Gastrointestinal endoscopy
    93. BOURGEOIS S; VANDEMIEROP F; HIELE M; SCHURMANS P; GEVERS A; VANSTEENBERGEN W; RUTGEERTS P
      PROSPECTIVE EVALUATION OF ENDOSCOPIC ULTRASOUND (EUS) GUIDED FINE-NEEDLE ASPIRATION (FNA) FOR PANCREATIC LESIONS

      Gastrointestinal endoscopy
    94. MACKEN E; GEVERS AM; HENDRICKX A; RUTGEERTS P
      MIDAZOLAM VERSUS DIAZEPAM IN LIPID EMULSION AS CONSCIOUS SEDATION FORCOLONOSCOPY WITH OR WITHOUT REVERSAL OF SEDATION WITH FLUMAZENIL

      Gastrointestinal endoscopy
    95. RUTGEERTS P; VERMEIRE S
      CLINICAL-VALUE OF THE DETECTION OF ANTIBODIES IN THE SERUM FOR DIAGNOSIS AND TREATMENT OF INFLAMMATORY BOWEL-DISEASE

      Gastroenterology
    96. DENHOND E; HIELE M; EVENEPOEL P; PEETERS M; GHOOS Y; RUTGEERTS P
      IN-VIVO BUTYRATE METABOLISM AND COLONIC PERMEABILITY IN EXTENSIVE ULCERATIVE-COLITIS

      Gastroenterology
    97. GEYPENS B; EVENEPOEL P; PEETERS M; LUYPAERTS A; RUTGEERTS P; GHOOS Y
      DIRECT DEMONSTRATION OF THE EFFECT OF LACTULOSE ON COLONIC BACTERIAL METABOLISM BY APPLICATION OF LACTOSE-(N-15)-UREIDE

      Gastroenterology
    98. VANVAERENBERGH W; TACK J; GEBOES K; GEVERS AM; RUTGEERTS P; LERUT T; JANSSENS J
      MICROSCOPIC BARRETTS-ESOPHAGUS - RELATIONSHIP TO ACID AND BILE REFLUXIN MAN

      Gastroenterology
    99. WOUTERS K; BAERT F; SEMPOUX C; TANGHE W; MARICHAL M; CUVELIER C; RUTGEERTS P; ECTORS N; GEBOES K
      ARE COLLAGENOUS AND LYMPHOCYTIC COLITIS ONE DISEASE - A HISTOLOGIC ANALYSIS OF 178 CASES

      Gastroenterology
    100. DRIESSEN A; ECTORS N; CHEN I; PEETERS M; VANCUTSEM E; FILEZ L; PENNINCKX F; RUTGEERTS P; GEBOES K
      CYTOPLASMIC ACCUMULATION OF P53 OCCURS IN INTESTINAL METAPLASIA ASSOCIATED WITH GASTRIC-ULCERS BUT NOT WITH DUODENAL-ULCERS

      Gastroenterology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 02:39:44